Why Is NeuroSense Therapeutics Surging by 70%? 46 Stocks Moving In Monday's Mid-Day Session
$AFIB
$AGRX
$AGTC
$ARMP
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Biotechnology: Pharmaceutical Preparations
Health Care
Gainers
- Evofem Biosciences, Inc. (NASDAQ:EVFM) rose 87.3% to $0.6965 amid the Supreme Court overturning Roe V Wade.
- Acutus Medical, Inc. (NASDAQ:AFIB) gained 82.4% to $0.9819 after the company announced the commercial launch of its left-heart access products.
- NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) surged 70% to $2.85 after the company reported results from a stage III ALS Biomarker study evaluating PrimeC. Preliminary results showed levels of disease-related biomarkers in people with ALS were steady, in contrast to a statistically significant decline portrayed in biomarkers when PrimeC was administered.
- Epizyme, Inc. (NASDAQ:EPZM) rose 60.4% to $1.53. Ipsen SA (OTC:IPSEY) agreed to acquire Epizyme at $1.45 per share for approximately $247 million, plus one contingent value right (CVR) per share.
- Axsome Therapeutics, Inc. (NASDAQ:AXSM) shares jumped 40.4% to $34.34 after the company received proposed labeling from the U.S. Food and Drug Administration for its treatment of major depressive disorder.
- Tenax Therapeutics, Inc. (NASDAQ:TENX) rose 35.3% to $0.42 after dipping more than 46% on Friday.
- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) jumped 28.7% to $0.4248.
- Hillstream BioPharma, Inc. (NASDAQ:HILS) gained 27.3% to $0.9632 after the company announced a collaboration with Sapien Biosciences in cancer treatments to evaluate the synergy of HSB-1216 with immune checkpoint inhibitors.
- InflaRx N.V. (NASDAQ:IFRX) shares rose 26.4% to $0.9870 after tumbling around 34% on Friday.
- NuZee, Inc. (NASDAQ:NUZE) gained 26.2% to $1.0788.
- FedNat Holding Company (NASDAQ:FNHC) rose 23.7% to $0.3216 after dipping over 20% on Friday. FedNat, last month, announced a $15 million investment by Hale Partnership in Monarch National Insurance Company.
- Clene Inc. (NASDAQ:CLNN) gained 22.4% to $3.55. Clene, last month, received a $3 million loan from the Maryland Board of Public Works to support production for its lead drug candidate CNM-Au8.
- Boxed, Inc. (NYSE:BOXD) surged 22.1% to $2.8263.
- Kiromic BioPharma, Inc. (NASDAQ:KRBP) rose 22.1% to $0.4397 after dropping more than 25% on Friday. Kiromic BioPharma recently announced a strategic pipeline shift to prioritize its allogeneic, non-engineered off-the-shelf product candidate, Deltacel/KB-GDT.
- Sigma Labs, Inc. (NASDAQ:SASI) gained 21.8% to $1.34.
- Panbela Therapeutics, Inc. (NASDAQ:PBLA) jumped 20.8% to $0.7394.
- Altamira Therapeutics Ltd. (NASDAQ:CYTO) gained 19.6% to $0.6110.
- Agile Therapeutics, Inc. (NASDAQ:AGRX) surged 19.1% to $1.37 amid the Supreme Court overturning Roe V Wade.
- Landos Biopharma, Inc. (NASDAQ:LABP) gained 18.8% to $0.7246. Landos recently named Gregory Oakes as President and Chief Executive Officer.
- Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) jumped 18.5% to $1.09.
- Applied Genetic Technologies Corporation (NASDAQ:AGTC) shares rose 17.7% to $0.7260 following a 25% drop on Friday.
- Armata Pharmaceuticals, Inc. (NYSE:ARMP) gained 16.7% to $3.91.
- NextPlay Technologies, Inc. (NASDAQ:NXTP) jumped 16.6% to $0.4215.
- Ebang International Holdings Inc. (NASDAQ:EBON) rose 16% to $0.4299. Ebang International announced the receipt of Nasdaq notification regarding minimum bid price deficiency.
- GreenLight Biosciences Holdings (NASDAQ:GRNA) gained 14.3% to $3.11.
- Remark Holdings, Inc. (NASDAQ:MARK) jumped 13.5% to $0.4316.
- Aspira Women's Health Inc. (NASDAQ:AWH) gained 13% to $0.5810.
- Martin Midstream Partners L.P. (NASDAQ:MMLP) shares gained 12.3% to $4.0975. Martin Midstream Partners recently filed for mixed shelf of up to $250 million.
- RedHill Biopharma Ltd. (NASDAQ:RDHL) rose 7.5% to $0.8812. RedHill Biopharma recently announced a cost reduction plan expected to generate operational cost savings of approximately $50 million over the next 18 months.
- Reed's, Inc. (NASDAQ:REED) rose 7% to $0.1498 after dropping more than 20% on Friday. Reed's, last month, posted a Q1 loss of $0.05 per share.
Losers
- Borqs Technologies, Inc. (NASDAQ:BRQS) shares fell 23% to $2.19 following effect of 1:16 reverse stock split.
- Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) dipped 22.1% to $0.8027.
- Benson Hill, Inc. (NASDAQ:BHIL) dropped 16.7% to $2.7550.
- Wrap Technologies, Inc. (NASDAQ:WRAP) fell 15.3% to $1.99.
- SIGA Technologies, Inc. (NASDAQ:SIGA) fell 15.3% to $11.04. SIGA Technologies recently announced approximately $13 million in procurement orders for oral TPOXX (tecovirimat).
- BioAtla, Inc. (NASDAQ:BCAB) dipped 15.2% to $3.0050.
- SSR Mining Inc. (NASDAQ:SSRM) fell 14.4% to $16.12. SSR Mining announced inclusion in the Russell 1000 Index.
- PLAYSTUDIOS, Inc. (NASDAQ:MYPS) dropped 13.6% to $4.68.
- Digital Ally, Inc. (NASDAQ:DGLY) fell 13.5% to $0.8207.
- Eargo, Inc. (NASDAQ:EAR) dropped 13.2% to $1.0850. Eargo strengthened financial position with up to $125 million strategic investment from Patient Square Capital.
- Avalo Therapeutics, Inc. (NASDAQ:AVTX) declined 12.5% to $0.46.
- Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) dropped 12.2% to $2.8265.
- Regis Corporation (NYSE:RGS) dipped 11.1% to $0.8104.
- Polestar Automotive Holding UK PLC (NASDAQ:PSNY) fell 10.3% to $11.66 amid post-SPAC merger volatility following the company's Friday debut as a public company.
- Sharecare, Inc. (NASDAQ:SHCR) shares fell 7.8% to $1.7699. Sharecare, last month, reported better-than-expected Q1 EPS and sales results, issued Q2 and FY22 guidance and reported a $50 million buyback.
- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) fell 6.5% to $1.7499. Tonix Pharmaceuticals recently reported pricing of $30 million private placement of convertible redeemable preferred stock.
